Clinical and immunological status of patients at ARV treatment initiation (N = 7278 people living with HIV with ARV treatment initiated between 2006 and 2017 in Kinshasa). by Nadine Mayasi Ngongo (11654868)

Subjects:

Evolution of the first-line ART regimen preferentially recommended by the WHO over time. by Nadine Mayasi Ngongo (11654868)

Subjects:

Evolution of median time between HIV screening and ART initiation, % patients treated within time with ARV treatment initiation year. by Nadine Mayasi Ngongo (11654868)

Subjects:

Proportion of patients who started treatment late according to CD4 and WHO stages and of patients treated within 7 days of diagnosis. by Nadine Mayasi Ngongo (11654868)

Subjects:

Evolution of the proportion of patients by OMS stage with AVR treatment starting year. by Nadine Mayasi Ngongo (11654868)

Subjects:

Other factors associated with late initiation of ART: Multiple logistic regression models. by Nadine Mayasi Ngongo (11654868)

Subjects:

Evolution of median CD4 cell count at ART initiation and OMS recommendations. by Nadine Mayasi Ngongo (11654868)

Subjects:

Sociodemographic status of patients at ART initiation (N = 7278 people living with HIV with ARV treatment initiated between 2006 and 2017 in Kinshasa). by Nadine Mayasi Ngongo (11654868)

Subjects:

ART regimen (at ART initiation) (N = 5807), N(%). by Nadine Mayasi Ngongo (11654868)

Subjects:

Construction of Chimeric HIV-1. by Yiying Zhang (198443)

HIV/AIDS infection and drug resistance of heterosexuals under baseline parameters in China. by Xin Jin (108988)

Subjects:

Data_Sheet_1_Increased Neutrophil Count and Decreased Neutrophil CD15 Expression Correlate With TB Disease Severity and Treatment Response Irrespective of HIV Co-infection.PDF by Lerato N. Ndlovu (9315464)

Newly diagnosed and recent HIV infections by province in Rwanda (2018–2020). by Gallican N. Rwibasira (11567195)

Subjects:

Prevalence of exposure categories at HIV diagnosis among participants to the HIV-positive cohort at the <i>Clinique médicale L’Actuel</i> in Montréal, Canada, over 1995–2019. by Katia Giguère (146393)

Subjects:

Proportion of recent infections per month among individuals with newly identified HIV infection in Rwanda (2018–2020). by Gallican N. Rwibasira (11567195)

Subjects:

HIV test rate and prevalence of HIV among TB patients from 2009–2018 stratified by sub-municipal. by Haruna M. Salisu (12988084)

Image 1_Chromosome 1 variants associated with decreased HIV set-point viral load correlate with PRKAB2 expression changes.png by Riley H. Tough (14432838)

Trend of TB/HIV co-infection in Suhum Municipal from 2009–2018. by Haruna M. Salisu (12988084)

HIV‑1 Infection Reduces NAD Capping of Host Cell snRNA and snoRNA by Barbora Benoni (18562553)

“…By applying the NAD captureSeq protocol to HIV-1-infected and uninfected cells, we revealed that four snRNAs (e.g., U1) and four snoRNAs lost their NAD cap when infected with HIV-1. …”

Socio-demographic and clinical characteristics of HIV-infected treatment-naïve individuals initiating ART. by Tosi M. Mwakyandile (16408705)